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Abstract
The wound care market is rapidly expanding due to the development of 
innumerable dressings that exhibit specific healing requirements for different 
wound types. The use of biomaterials as suitable wound dressing material is highly 
advantageous due to their biocompatibility, biodegradability, and non-toxicity. 
Cyanobacteria have been widely explored for their potential applications in wound 
healing, as they are the rich source of bioactive compounds with antibacterial, anti-
tumor, antiviral, antioxidant, and antifungal activities. In recent years this group 
of organisms has been widely studied due to their immense potential in biomedical 
applications. Although their different bioactivities can support wound healing 
in different ways, very few forms have proven utility as a wound-healing agent. 
This chapter gives an insight into the potential of cyanobacteria in wound healing. 
Different bioactive compounds present in variable forms of cyanobacteria and their 
associated activities were reported to support tissue regeneration and wound heal-
ing acceleration. As the demand for cost-effective, bioactive wound care products 
is ever increasing, these organisms have immense potential to be utilized for the 
development of bioactive wound dressings. Hence, various bioactive compounds 
of cyanobacteria, their associated activities, and roles in wound healing have been 
briefly reviewed in this chapter.
Keywords: Cyanobacteria, wound healing, bioactive compounds, hemostatic, 
antioxidant activities
1. Introduction
Wound healing involves various interactions between cellular, molecular, bio-
chemical, and physiological activities, making the process very complex, dynamic, 
and precisely programmed. Wound healing involves four phases: hemostasis, inflam-
mation, proliferation, and remodeling to restore the structural, functional, and 
physiological integrities of injured tissues [1]. This process results in the regeneration 
and replacement of injured tissue at the wound site [2]. Several nutritional factors 
are required for proper cellular differentiation, immune functioning, and collagen 
formation [3]. Any interruption, aberrance, or prolongation in the healing process 
would extend the tissue damage and thus prolong the repair process, contributing to 
chronic wound healing [4]. In recent years there has been accelerating demand for 
various wound dressings, each with specific characteristics, considering the distinc-
tive healing requirements of various wound types. Various synthetic and natural 
products have been widely explored for their efficiency and accelerating wound heal-
ing abilities to accomplish the need for suitable dressing for a particular wound type.
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The nonabsorbent and non-biodegradable nature of synthetic products makes 
these products unsuitable for healing purposes [5]. Medicinal plants are widely 
being explored for their utility in wound healing, and the ancient knowledge of 
medicinally essential plants, their increased popularity and utility further raised 
interest in exploring new natural products useful for the healing process. Various 
studies confirmed the anti-inflammatory, pro-collagen synthesis, antioxidant and 
antibacterial activities of natural products from plants and microbes, potentially 
beneficial for healing purposes. Biocompatibility and the presence of various bioac-
tive phytochemicals in natural products efficiently promote the healing process 
and make them economically suitable for designing and fabricating dressings 
[6]. To satisfy the demand for new natural therapeutic agents for wound healing 
and to decrease the average costs involved in their development, researchers are 
screening organisms from overlooked microbial sources having the potential to be 
used as effective wound healing agents such as proteobacteria, bacterioidetes, and 
cyanobacteria.
Cyanobacteria are ubiquitous, oxygenic photosynthetic bacteria having diverse 
nature and can be found in various forms like unicellular and filamentous, marine 
and freshwater, free-living symbiotic, edible, and poisonous. [7, 8]. This group of 
organisms has immense potential to produce many primary and secondary metabo-
lites thus are known to perform potent biological activities. Produced secondary 
metabolites are low molecular weight, natural organic compounds, essential for 
average growth and development of these organisms. These metabolites have a wide 
range of applications in the field of medicines, industries, and biotechnology. These 
metabolites are a rich source of bioactive compounds, and cyanobacteria are the 
most promising organisms to produce them. In the last few decades, cyanobacteria 
have gained lots of attention for their medicinal values and wound healing proper-
ties. They are the choice of organisms due to their easy availability, fast regenera-
tion, and huge diversity which have further expanded interest of researchers in 
their values as medicine and functional foods [9]. Thus, their potential as a good 
source of new therapeutic lead compounds has been realized during the last two 
decades. Cyanobacterial secondary metabolites show different medicinally essential 
activities such as antitumor, antibacterial, antifungal, antiviral, anti-inflammatory, 
immunomodulatory effects, and protease inhibition [10]. These biological activi-
ties are helpful to promote wound healing in different ways. Despite their potent 
biological activities, very few cyanobacterial forms are known to be useful in 
wound healing acceleration. Thus, this chapter presents an overview of bioactive 
compounds of cyanobacteria responsible for their various biological activities that 
promote the wound healing process by affecting different phases and factors of 
wound healing.
2. Important wound healing properties of cyanobacteria
2.1 Antibacterial activity
Antibacterial compounds are the molecules that kill or inhibit the growth of 
bacteria by affecting their physiological processes. Increased temperature due to 
inflammation caused by immune response and humidity caused by accumulation of 
fluid at the wound surface, make the wounds more vulnerable for bacterial infec-
tions. Once the wounded site came in contact with bacteria, they can penetrate 
underlying tissues, leading to life-threatening infections. To deal with such patho-
logical conditions, effective wound management practices are essentially required. 
To improve the healing process and to reduce the wound bacterial colonization as 
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well as infection at the wound site, the use of systematic antibiotics and the applica-
tion of antimicrobial-loaded wound dressings are viable options to overcome the 
issue of infection and associated delay in healing. Considering the fact that usage 
of antibiotics has led to the increasing emergence of multidrug-resistant (MDR) 
strains of bacteria which negatively affects the healing process and worsens this 
issue [11]. Thus, there is a need to develop/discover an effective wound manage-
ment material which can efficiently cure wound in such conditions. Several cyano-
bacteria are known to produce intracellular and extracellular bioactive compounds 
that possess antibacterial activities. [12]. These compounds are effective against 
various bacterial strains like Staphylococcus epidermidis, Bacillus cereus, Escherichia 
coli, Staphylococcus aureus, Salmonella typhi, Staphylococcus albus, Micrococcus flavus, 
Bacillus subtilis, Pseudomonas aeruginosa, Serratia marcescens, Mycobacterium smeg-
matis, Streptococcus pyogenes, and some other Gram-positive and Gram-negative 
bacteria. [13–19]. However, the production of antibacterial agents depends upon 
the composition of the culture medium, incubation period, pH, temperature, and 
light intensity during the growth of the selected cyanobacteria [20]. Table 1 shows 
the bioactive compounds produced by different cyanobacterial strains, potentially 
useful for their antibacterial activity.
2.2 Antifungal activity
Devastating chronic wound infection is a significant reason for trauma world-
wide, which causes serious public health problems. Majorly bacteria are responsible 
for infections in wounds, but very few recent studies analyzed both fungal and 
bacterial communities in the microbiome of chronic wounds, suggesting the role of 
fungi as underappreciated agents that leads to complications at the wound site [33]. 
Cyanobacterial Strain Bioactive Compounds Reference
Nostoc commune Noscomin,Comnostins [13, 21]
Nostoc sp. Comnostin, Muscoride A, Dodecahydrophenanthrene, 
4-methylchrysazin, Norharmane and 4-hydroxy-7-
methylindan-1,carbamidocyclophane, Nostocarboline
[13, 16, 22]
Nostoc muscorum Muscoride A [23]
Lyngbya majuscula Tanikolide [24]
Microcoleus lacustris Abietane [25]
Oscillatoria redekei Coriolic acid [14]




Lyngbya majuscula Pitipeptolides, malyngolid [29, 30]
Scytonema sp. Scytonemin [31]
Nostocspongiaeforme Tenuecyclamides [31]
Micrococcus lacustris Norbietane [32]
Fischerella sp. hapalindole T, ambiguine-I isonitrile [14, 18]
Anabaena Exopolysaccharide [32]
Tolypothrix tenuis Exopolysaccharide [32]
Table 1. 
Bioactive compounds of cyanobacterial strains possess antibacterial activity.
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Hard to heal wounds like diabetic foot ulcers (DFUs) are majorly infected by mem-
bers of the genus Candida [34, 35]. Prolong infection along with delayed healing 
makes these wound types chronic and challenging to manage. Over 75% Candida 
species were isolated by DFUs. In allergic rhinitis, respiratory disease, diabetic foot 
ulcers, other allergic fungi such as Cladosporium spp., Aspergillus spp., Penicillium 
spp., Alternaria spp., Pleospora spp., and Fusarium spp. are reported as critical 
infection-causing agents. Pathogenic and opportunistic fungi such as Candida 
spp., Trichosporon asahii, and Rhodotorula spp. are reported to associate with stalled 
open wounds or wounds resulting in an amputation [33]. Antifungal drugs to cure 
infected wounds are limited due to their high cost and side effects. So there is an 
emerging need to discover a new natural fungicidal agent. Many cyanobacterial 
compounds have been reported to possess inhibitory effects against different patho-
genic strains of fungi [36]. They are an excellent source of various bioactive com-
pounds that belong to several different chemical classes like peptides, polyketides, 
and alkaloids [37]. Bioactive antifungal compounds like nostodione, nostocy-
clamide, carazostatin, scytophycins, tolytoxin, phytoalexin, fisherellin, hapalindole 
are isolated from different strains of cyanobacteria [38]. Organic extracts of several 
cyanobacteria like Oscillatoria latevirens, Chrococcus minor, Phormidium corium, 
Lyngbya martensiana, Lyngbya aestuarii, Aphanothece bullosacrude and Microcystis 
aeruginosa have potential antifungal activity against Candida albicans and Aspergillus 
flavus [19]. Table 2 shows various bioactive compounds of cyanobacteria possessing 
antifungal activity.
2.3 Antioxidant activity
Antioxidants are substances that prevent oxidation. They balance oxidative stress 
by eliminating free radicals and allowing the regeneration of tissue by repairing the 
cells [50]. Respiratory burst generates oxidants during wound healing; production 
of these oxidants supports acceleration in healing. These produced oxidants act as a 
messenger and thus promote healing. However, a delicate balance between oxidants 
and antioxidants required to control the progress of the wound. For normal wounds, 
low physiology levels of reactive oxygen species and oxidative stress are required at 
wound sites. Whereas oxidative stress and impaired wound healing led by their over-
exposure. To improve the level of oxidative stress, increased level of antioxidants is 
expected, which further help in healing acceleration [51]. Antioxidants also preserve 
Cyanobacterial Strain Bioactive Compounds Reference
Scytonema hofmanni Cyanobacterin [39]
Calothrix fusca Calophycin [40]
Hapalosiphon fontinalis Fontonamide, hapalindole [38, 41]
Tolypothrix tenuis Toyocamycin, Tubercidin [42, 43]
Lyngbya majuscula Majusculamide C, Hectochlorin, Tanikolide [24, 44, 45]
Hyella caespitosa Carazostatin [46]
Nostoc sp. Nostocyclamide [47]
Nostoc commune Nostofungicidine, Nostodione [48, 49]
Scytonema sp. tolytoxin, phytoalexin, scytophycins [38]
Fischerella muscicola fisherellin [38]
Table 2. 
Antifungal activity of bioactive compounds isolated from different cyanobacterial strains.
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and stimulate the function of immune cells against homeostatic disorders. Therefore, 
their increased levels can improve the immune response and accelerate wound 
healing [52]. Accumulation of low molecular weight iron at the wound site also 
increases inflammation and microbial invasion of the wound [53], suggesting the 
requirement of a chelating agent to achieve proper healing. Production of various, 
chemically diverse groups of secondary metabolites from cyanobacteria established 
their industrial significance and made them an excellent source of antioxidants that 
facilitate the formation of the body’s defense mechanism against free radical induced 
damages to cells. Their antioxidant and metal chelating ability are reportedly due to 
phytonutrients and pigments present in them [54]. Their cell-free extracts possess 
free radical scavenging property, metal chelating activity, and deoxyribose protec-
tion [55]. The antioxidant properties of the cyanobacterial cell extracts are imparted 
by the total phenol and total flavonoid content present in the extracts. The free 
radical scavenging, metal chelating, and antioxidative damage protecting proper-
ties of cyanobacterial cell extracts are presumably linked with varied quantities of 
polyphenolics, gallic, chlorogenic, caffeic, vanillic, and ferulic acids, flavonoids, 
quercetin, and kaempferol present in them. Exopolysaccharides of cyanobacteria also 
exhibit good antioxidant and anticoagulant activities. They can also induce oxidants 
and antioxidant enzymes and are known as immunostimulators [56]. Exopolymers 
of three strains of Anabaena and Tolypothrix tenuis exhibited antioxidant activities 
against O2·, H2O2, OH·, and NO·. These polymers also possess Fe2
+ chelating activity, 
helps in preventing the invasion of pathogenic organisms at the wound site. A strong 
correlation of sulfate content against superoxide and nitric oxide radicals scavenging 
activity of exopolymers was found, whereas H2O2 scavenging ability and reducing 
power were contributed by phenols present in them. The overall reducing power and 
superoxide control strongly related to their iron chelation ability [57]. The high-
est phenolic, flavanoid, and phycobiliprotein content in Lyngbya sp. possessed the 
highest 2,2-diphenyl-1-picrylhydrazyl (DPPH) activity. The antioxidant potential 
of Spirulina sp. was presumable related to the presence of alcoholic and phenolic 
OH groups in the cellular structure of the organism [54]. Phenolic content in metha-
nolic extracts of Anabaena sp., Nostoc sp., Nostoc commune, Nodularia spumigena, 
Leptolyngbya protospira, Phormidiochaete sp. and Arthrospira platensis reported higher 
antioxidant activity than their aqueous extracts [58, 59]. Similarly, ethanolic extracts 
of Phormidium fragile, Lyngbya limnetica, Scytonema bohnerii and Calothrix fusca 
possess antioxidant ability [60]. Cyanobacterial pigments also possess antioxidant 
activities. In Lyngbya and Phormidium sp. peroxyl and hydroxyl radicals, scavenging 
ability was reported to be linked with the presence of covalently linked tetrapyrrole 
chromophore with phycocyanobilin [61]. Phycocyanin, a type of phycobiliprotein 
isolated from Spirulina platensis and Geitlerinema sp., reported to have antioxidant 
and anti-inflammatory properties and ability to scavenge peroxyl, hydroxyl, and 
superoxide radicals [62]. Phytonutrients, pigments, and polysaccharides of cyano-
bacteria exhibit good antioxidant, anticoagulant, and metal chelating ability [54, 
56]. Polysaccharidic exopolymers of three strains of Anabaena and Tolypothrix tenuis 
possessed antiradical and Fe2+ chelating activity. All these exopolymers exhibited 
antioxidant activities against O2
•, H2O2, OH
•, and NO•, thus helps in the rapid healing 
of the wound [57].
2.4 Immunomodulatory and anti-inflammatory effects
Inflammation is a local, protective and physiological response to microbial inva-
sion or injury. The magnitude of the inflammatory response is crucial: insufficient 
responses result in immunodeficiency, whereas excessive responses cause morbidity 
and mortality. Therefore, homeostasis and health are restored when inflammation 
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is limited by anti-inflammatory responses [63]. Natural compounds have gained 
lots of attention in treating various types of inflammations to reduce the reaction 
of the immune system against pathogens, toxic compounds, and damaged cells. 
The immune system actively participates in homeostasis, re-establishment, fol-
lowing tissue injury via multiple mechanisms, and plays a critical role throughout 
the wound healing process. Immune system control to promote tissue repair and 
regeneration is an attractive approach when designing regenerative strategies. 
Now a day, the multifunctional immunomodulatory properties of cyanobacteria 
are gaining much attention in the field of medicine. Cyanobacteria produce vari-
ous metabolites with different chemical structures, including small molecules of 
peptides and proteins, polysaccharides, fatty acids, and their derivatives, pos-
sessing anti-inflammatory activities [64]. Different cyanobacterial components 
control the release of certain cytokines from human monocytes and macrophages. 
Depending on the wound microenvironment, they also can reduce or activate the 
production of reactive oxygen species from neutrophils [65]. Immunomodulatory 
effects of cyanobacteria highly induce activation of both types of immune cells 
which could promote wound debridement, accelerate re-epithelization, and 
wound closure [66]. Edible cyanobacterial forms are known for their immune-
boosting abilities, and many studies have proven their immunomodulatory and 
anti-inflammatory effects. Spirulina is a widely consumed cyanobacterial strain 
because of its extraordinary neutraceutical and pharmaceutical values. Dietary 
effects of Spirulina platensis showed increased phagocytic and increased antigen 
production and increased natural killer cell-mediated antitumor activity in the test 
animals under study [67]. Daily consumption of Spirulina stimulates and promotes 
the immune system by increasing the phagocytic activity of macrophages, induces 
antibodies and cytokines production, increases accumulation of natural killer cells 
into tissues, and activates T and B cells [68]. Daily consumption of Spirulina for 
16 consecutive weeks reported a significant rise in plasma IL- 2 concentration and 
a significant reduction in IL-6 concentration in humans [69]. Nonadecane and 
9-Eicosyne in Spirulina were supposed to be responsible for the anti-inflammatory 
effects [70]. A high-molecular-weight polysaccharide extracted from the cyano-
bacterium Spirulina is known as Immulina®, a potent activator of innate immune 
cells and exerts inhibitory effects in the induced allergic inflammatory response 
[71, 72]. It also exhibits anti-inflammatory properties and can inhibit the release 
of histamine from mast cells [47]. Gama and alpha-linolenic acid are the fatty 
substances extracted from Spirulina and Aphanizomenon flos-aquae, respectively, 
which inhibit the formation of inflammatory mediators [48]. Similarly, Nostoc is an 
edible, largely consumed cyanobacterial form after Spirulina. Polysaccharide-rich 
extracts of Nostoc commune could be potentially used for macrophage activation 
and consequently inhibit the leukemic cell growth and induce monocytes/macro-
phages when used to treat human monoblastoid leukemia U937 cells [73]. Different 
immunomodulating activities of Microcystis aeruginosa, Synechocystis aquatilis, 
Oscillatoria redekei, Anabaena flos-aque, Aphanizomenon flos-aquae, Oscillatoria 
rubescens, Oscillatoria tenuis have also been reported [74] their different cell extracts 
variably promote the proliferation of lymphocytes. On the other hand, some spe-
cies of cyanobacteria that contain cytotoxic metabolites (cyanotoxins) can cause 
immunotoxicity and immunosuppression. The property of immunotoxicity is well 
reported in cyanobacterial bloom extracts containing microcystin [75]. Treatment 
with microcystin showed inhibition of lipopolysaccharide-induced lymphopro-
liferation and decreased numbers of antibody-forming cells; this results in immu-
nosuppression in mice that were immunized using T-dependent antigen sheep red 
blood cells. A form of cyanobacterial toxin, cylindrospermopsin, is an important 
water pollutant having broad biological activity. Cylindrospermopsin promotes 
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significant production of pro-inflammatory mediator tumor necrosis factor α and 
reactive oxygen species when introduced in macrophages cells [76]. Effmert in 1991 
reported aqueous extracts of different cyanobacterial species Microcystis aeruginosa, 
Synechocystis aquatilis, Oscillatoria redekei, Anabaena flos-aque, Aphanizomenon 
flos-aquae, Oscillatoria rubescens, Oscillatoria tenuis possess strong immunomodulat-
ing activities [74]. Aqueous extract of the marine cyanobacterium, Trichodesmium 
erythraeum, ethyl acetate extract of non-edible blue-green algae Geitlerinema 
splendidum exhibit anti-inflammatory activity [77, 78]. In chronic wounds where 
a coordinated wound healing cascade fails to progress beyond the inflammatory 
phase, the anti-inflammatory activity of cyanobacteria helps in the wound healing 
by proliferation, matrix deposition, and ultimately, wound resolution [79]. During 
the last decade, several bioactive compounds have been isolated from cyanobacteria 
having anti-inflammatory properties that suggest their importance and potential in 
developing a huge market of wound healing aids [10]. Different classes of cyano-
bacterial bioactive compounds like phycobilins, phenols, polysaccharides, steroids, 
and terpenoids possess potential anti-inflammatory effects. Selected anti-inflam-
matory compounds of different cyanobacterial strains are listed in Table 3.
2.5 Hemostatic activity
For people throughout the world, traumatic injuries have been a challenge. 
Considering technological advancements made through age’s trauma remains a leading 
cause of human morbidity and mortality [90]. Excess bleeding can cause delayed 
wound healing, hematoma formation, infection, dehiscence, and necrosis. Patients 
suffering from trauma and its consequent hemorrhage essentially require the estab-
lishment of hemostasis by topical wound dressings. Constriction of blood vessels, the 




Bioactive Compound Cyanobacterial 
Strain
References
Amino acids and 
peptides




Shinorine Anabaena variabilis [82]
Phycocyanin Spirulina sp [72]
Ethyl tumonoate A Oscillatoria 
margaritifera
[83]
Cyanopeptolin Microcystis spp [84]
Polysaccharide Sacran Aphanothece sacrum [85]





Pigment Scytonemin Scytonema [87]
Others Coibacin A Oscillatoria sp. [88]




Bioactive compounds of cyanobacterial strains possessing anti-inflammatory properties.
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and significant steps of hemostasis. Therefore, any effort made to accelerate any or 
all phases above can help achieve hemostasis [91]. The role of cyanobacteria and 
algae in hemostasis is significantly less known and identified. In the majority, their 
antithrombic activities useful to cure thrombosis-related diseases are reported. The 
antithrombic activity of Spirulan, a sulfated polysaccharide of Arthrospira platensis has 
been widely known. Spirulan is helpful to directly decrease the activity of thrombin 
and factor X activated, procoagulant proteins that can be used to prevent thrombus 
formation and partial lysis of thrombus [92]. Similarly, Microcystis aeruginosa and 
different cyanobacteria blooms produce probable fVIIa-soluble Tissue Factor (fVIIa-
sTF) inhibitors [93]. Vitamin-K-dependent clotting factors like thrombin and fVIIa 
are associated with bleeding, related complications, and disorders. These factors can 
induce excessive bleeding when treated with vitamin-K antagonists. M. aeruginosa 
produces bioactive compound Aeruginosin, which shows positive fVIIa-sTF inhibi-
tory activity. Daily consumption of aqueous extract of Spirulina platensis, containing 
a high dose of phycocyanin was found safe for when tried on the human to test its 
anticoagulant activity and platelet activation ability. The studied extract is also suit-
able for providing rapid and robust relief in chronic pain. The extract also improved 
the liver function and metabolism by reducing the activity of aspartate transaminase 
and alanine transaminase enzymes [94]. C-phycocyanins extracted from Spirulina 
platensis possess significant anticoagulation, antioxidant, and prevention of DNA 
damage activities [95]. Exopolysaccharides of A. platensis possess antiatherogenic and 
anti-thrombogenic activities [96]. Although the significant roles of cyanobacterial 
and algal polysaccharides as antioxidants, antiviral, antitumoral, and anticoagulant 
have been well-documented and reviewed [10] the single report was found to date 
mentioning the role of cyanobacterial exopolymers (EPs) isolated from four desert 
cyanobacteria (Tolypothrix tenuis and three species of Anabaena) in hemostasis. These 
exopolymers were potentially beneficial to reduce activated partial thromboplastin 
time (APTT, a measure of how long blood takes to clot) and prothrombin time (PT, a 
measure of how long blood plasma takes to clot) by 16–41% and 12–65% respectively. 
The gravimetric method of thrombogenicity assessment showed that the blood clot 
formed by the cyanobacterial EPs was heavier vis a vis glass (positive control) and thus 
was thrombogenic. Similar studies can open the treasure of hidden potential of bioac-
tive compounds of cyanobacteria in hemostasis which needs to be explored more.
2.6 Wound healing effect of cyanobacteria
Specific healing requirements of a wound widen the scope of identifying more 
natural, economic, and effective wound healing agents, which gave extraordinary 
rise to the development of many synthetic and natural products useful as suitable 
wound healing dressing materials. Various natural products obtained by plants are 
widely known for their medicinal properties, facilitating wound healing. Bioactive 
secondary metabolites like alkaloids, essential oils, flavonoids, tannins, terpenoids, 
saponins, and phenolics are present in plant-based natural products. These com-
pounds possess various activities like anti-inflammatory, antioxidant, antibacterial, 
procollagen synthesis, etc., and efficacy to modulate one or more phases of the 
wound healing process which further help in accelerated tissue regeneration dur-
ing healing [97]. Similarly, cyanobacterial bioactive compounds possess important 
medicinal properties like immunostimulating, antiviral, antioxidant, antibacterial, 
antifungal, antialgal, and anticancerous activities [38, 98] but very few are known for 
their wound healing potential. The blue-green microalgae Spirulina has been widely 
studied for its wound healing potential and possess antioxidant, antimutagenic, anti-
viral, anticancer, anti-allergic, immune-enhancing, hepatoprotective, blood vessel 
relaxing, and blood lipid-lowering activities [99, 100]. The C-phycocyanin pigment 
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of Spirulina promoted proliferation, regeneration, and migration of cells tested on 
cultured human keratinocytes. A similar set of experiments on Sprague–Dawley male 
rats showed re-epithelization, neovascularization, presence of inflammatory cells, 
granulation of tissue amount, and maturation during wound healing [101]. Aqueous 
extract of Spirulina platensis showed proliferation, migration, and enhanced closure 
rate of wound area within 24 hours when tested on human dermal fibroblast cells 
(HDF) [102]. Compounds like cinnamic acid, narigenin, kaempferol, temsirolimus, 
phosphatidylserine, and isomeric derivatives were presumably involved in the accel-
erated wound healing activity of the studied aqueous extract of Spirulina platensis. 
Antibacterial and antioxidant activities of Spirulina are useful to improve the immu-
nity of skin cells, and thus burn cream of ethanolic extract of Spirulina along with 
gold nanoparticles has been formulated. To reduce the pain by numbing the injured 
area, Lidocaine has been added to the cream as an anesthetic, sodium dodecyl sulfate, 
and glycerine used for skin moisturization [103]. Polylactic acid (PLA), polyethylene 
oxide, and PHB (polyhydroxybutyrate) extracted from Arthrospira LEB 18 strain 
used to prepare biodegradable, biocompatible nanofibrous scaffolds. Properties of 
prepared scaffolds like increased conductivity, higher mechanical durability with 
enhanced elasticity, tensile strength, and breaking elongation supported nutrient, 
growth factors, and metabolism byproducts distribution at the wound site [104]. 
Scaffolds of poly-D, L-lactic acid (PDLLA) associated with LEB 18 biomass showed 
better adherence to the wound, increased cell viability, and more moldable when 
compared with classic PDDLA [105]. Natural wound healing processes can be 
promoted by such biomatrices produced from Arthrospira, and also they can mini-
mize the risk of infection [104]. PCL nanofiber loaded with Spirulina extract was 
fabricated as a cutaneous wound dressing material. The designed dressing showed 
enhanced wound regeneration ability by modulating intra- and extracellular ROS 
with enhancing antioxidant mechanism and increased fibroblast viability under oxi-
dative stress [106]. Synechococcus elongatusa, a naturally occurring photoautotrophic 
cyanobacterium promoted angiogenesis and burn wound repair in mice. The pro-
motion of interleukin-6 expression and secretion of extracellular vesicles probably 
induced pro-angiogenic and wound healing effects in the studied animals [107]. In 
diverse marine, freshwater, and terrestrial organisms, ultraviolet-absorbing myco-
sporine-like amino acids (MAAs) are found as secondary metabolites. Nostoc flagel-
liforme and Nostoc commune, are widely known for their edible values and reported as 
natural resources of MAAs. These secondary metabolites possess several beneficial 
effects and are useful as sun-screening cosmetics, antioxidants, and pharmaceuticals 
[108]. In wound healing, MAAs modulate skin fibroblast proliferation and activate 
adhesion kinases, extracellular signal-regulated kinases that promote acceleration 
in wound healing. Extensive researches are conducting on MAAs to identify their 
potential as a new wound healing agent to be explored as a novel biomaterial for 
wound healing therapies [109]. Cyanobacterial glycans are known as hydrogels that 
imbibe large amounts of biofluids [110]. This property of glycans extremely use-
ful for targeted drug delivery in chronic wound cases [111], where they have been 
exploited for delivery of low molecular weight drugs and macro-molecular payloads 
(hormones, peptide, and protein drugs) [112]. Cyanobacteria have been widely 
explored and studied for their immense potential in various biomedical applications, 
but very few are reported for their accelerated wound healing abilities. Most of the 
studies have been conducted on Spirulina which is known for its extraordinary neu-
traceutical and pharmaceutical values. As these organisms are phototrophic and have 
minimal growth requirements, they can be easily regenerated, and also their huge 
diversity makes them suitable candidates for research, having hidden potential for 
wound healing. Further, they can be explored to develop bioactive and cost-effective 
wound dressing materials, suitable for all sections of society.
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3. Conclusions
The ever-increasing demand for effective bioactive dressings suitable for dif-
ferent types of wounds is rapidly expanding the wound care market at diverse 
levels. Cyanobacteria are known for their numerous biomedical applications; 
thus, recently, they are a widely explored group of organisms. The cyanobacterial 
bioactive compounds possess antiviral, antifungal, antibacterial, antitumor, anti-
inflammatory, and antioxidant activities suitable to accelerate wound healing even 
in chronic conditions by controlling different phases and factors of the wound. 
Cyanobacteria are known for the abundant availability of versatile bioactive com-
pounds and their associated properties, but unfortunately, very few forms of cyano-
bacteria are known for their role in wound healing. Their easy cultivation, colossal 
diversity, and different biological activities can make them suitable candidates for 
research. Further, they can be explored more in the field of biomaterials for design-
ing and fabrication of low-cost, biocompatible, and biodegradable wound dressings.
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